We speculate that it can be associated with subclinical insulin resistance and hyperinsulinemia independent of adiposity, since an altered adipokine profile (high level of leptin and low level of adiponectin) leads to metabolic derangements. Here, ADIPOQ is linked to Insulin resistance.